Zions Bancorporation, National Association’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.6K Buy
198
+27
+16% +$5.6K ﹤0.01% 614
2026
Q1
$38.4K Sell
171
-169
-50% -$42.1K ﹤0.01% 591
2025
Q4
$81.9K Buy
340
+69
+25% +$17.6K ﹤0.01% 545
2025
Q3
$74.2K Buy
271
+65
+32% +$17.8K ﹤0.01% 502
2025
Q2
$53.1K Buy
206
+5
+2% +$1.19K ﹤0.01% 509
2025
Q1
$45K Buy
+201
New +$46.9K ﹤0.01% 511

Other funds holding RMD

Zions Bancorporation, National Association's RMD Position: Q2 2026 in Review

Zions Bancorporation, National Association increased its ResMed (RMD) stake by 16% in Q2 2026, buying an estimated $5.6K and bringing the position to 198 shares worth $38.6K. The position accounts for ﹤0.01% of the portfolio, ranked #614.

Zions Bancorporation, National Association first reported a position in RMD in Q1 2025 and has held it in 6 quarters since. The position peaked at $81.9K in Q4 2025. 346 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Zions Bancorporation, National Association held 198 shares of ResMed worth $38.6K as of Q2 2026.
  • Zions Bancorporation, National Association bought 27 ResMed shares in Q2 2026, an estimated $5.6K.
  • ResMed made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #614 holding.
  • Zions Bancorporation, National Association first reported a position in ResMed in Q1 2025 and has held it in 6 quarters since.
  • Zions Bancorporation, National Association's ResMed position peaked at $81.9K in Q4 2025.
  • 346 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.